Showing results (1841-1850 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 21, 2004
The generic alternative in schizophrenia: opportunity or threat?Philippe Nuss, David Taylor, Marc De Hert, et al.CNS Drugs|August 28, 2004
Ropinirole: for the treatment of restless legs syndromeSusan M Cheer, Lynne M Bang, Gillian M KeatingCNS Drugs|August 5, 2004
Zolpidem 'as needed': methodological issues and clinical findingsRaymond CluydtsCNS Drugs|August 5, 2004
Experience with zolpidem 'as needed' in primary care settingsGöran Hajak, Peter GeislerCNS Drugs|March 3, 2005
Prevention of schizophrenia: can it be achieved?Cheng Lee, Thomas H McGlashan, Scott W WoodsCNS Drugs|March 3, 2005
US FDA-approved disease-modifying treatments for multiple sclerosis: review of adverse effect profilesSteven L Galetta, Clyde MarkowitzCNS Drugs|March 3, 2005
Pregabalin: as adjunctive treatment of partial seizuresGreg Warner, David P FiggittCNS Drugs|October 6, 2004
Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of lifeMartin Lambert, Dieter NaberCNS Drugs|June 30, 2005
Place of drug therapy in the treatment of carotid stenosisNorberto Andaluz, Mario ZuccarelloCNS Drugs|January 20, 2004
Direct-to-consumer marketing of prescription drugs: a current perspective for neurologists and psychiatristsMatthew F HollonPageof 211